Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SDI GROUP PLC Interim / Quarterly Report 2022

Dec 7, 2021

7905_er_2021-12-07_d8e49e0e-8286-47c9-aaf3-25d00f44678d.html

Interim / Quarterly Report

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 7523U

SDI Group PLC

07 December 2021

SDI Group plc

("SDI", "SDI Group", the "Company", or the "Group")

Interim results for the six months ended 31 October 2021

SDI Group plc, the AIM quoted Group focused on the design and manufacture of scientific and technology products for use in digital imaging and sensing and control applications, is pleased to announce another strong set of results and solid operational progress for the six months to 31 October 2021.

Financial Highlights

·      Revenue increased by 75% to £24.7m (FY21 H1: £14.1m), including 42% organic growth

o  Continued strong contribution from Atik Cameras due to one-time COVID-19-related contracts, expected to complete by January 2022

o  £4.6m sales contribution from Monmouth Scientific and Uniform Engineering, acquired in FY21 H2

o  Organic sales growth in all other businesses averaged 22%

·      Reported operating profit increased by 105% to £5.2m (FY21 H1: £2.5m)

o  Adjusted operating profit* for the period increased by 82% to £5.8m (FY21 H1: £3.2m)

·      Reported profit before tax increased by 115% to £5.1m (FY21 H1: £2.4m)

o  Adjusted profit before tax* increased by 89% to £5.7m (FY21 H1: £3.0m)

·      Reported diluted EPS increased by 76% to 3.43p (FY21 H1: 1.95p)

o  Adjusted diluted EPS* increased 59% to 3.92p (FY21 H1: 2.47p)

·      Cash generated from operations decreased by 6% to £4.4m (FY21 H1: £4.7m)

o  Prior year included a substantial build-up of customer down payments related to the one-time COVID-19-related contracts

·      Net cash** at 31 October 2021 of £1.1m (30 April 2021: £0.8m)

o  Deferred consideration outstanding was £nil (30 April 2021: £2.35m)

* before reorganisation costs, acquisition costs, amortisation of acquired intangibles and share based payment costs 

** cash and cash equivalents less bank finance

Operational Highlights

·  Our FY21 acquisitions of Monmouth Scientific and Uniform Engineering have performed ahead of management's expectations and have been fully integrated into the Group

·    On 1 November 2021, we renewed and expanded our committed loan facility with HSBC to £20m, with a further accordion option of an additional £10m (at the discretion of HSBC), which, with our current net cash position and strong cash flow, provides sufficient funding for acquisition opportunities

Ken Ford, Chairman of SDI Group, said:

"We are pleased to report yet another strong set of financial results. SDI Group continues to execute on its business model, investing in quality businesses that are able to grow while generating cash. We look forward to delivering a full year performance in line with market expectations1."

1 Analysts from our Broker finnCap Limited and from Progressive Equity Research regularly provide research on the Company, and the Group considers the average of their forecasts to represent market expectations for FY 2022 being Revenue of £45.05m and Adjusted2 Profit Before Tax of £9.2m

Enquiries

SDI Group plc                                                                                                   01223 320480

Ken Ford, Chairman

Mike Creedon, CEO

Jon Abell, CFO

www.thesdigroup.net

finnCap Ltd                                                                                                        020 7220 0500

Ed Frisby/Kate Bannatyne/Milesh Hindocha - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

JW Communications                                                                                     07818 430877

Julia Wilson - Investor & Public Relations

About SDI Group plc:

SDI designs and manufactures scientific and technology products for use in digital imaging and sensing and control applications including life sciences, healthcare, astronomy, manufacturing, precision optics and art conservation. SDI operates through its company divisions: Atik Cameras, Synoptics, Graticules Optics, Sentek, Astles Control Systems, Applied Thermal Control, MPB Industries, Chell Instruments, Monmouth Scientific and Uniform Engineering.

SDI continues to grow by developing its own technology advancements and by improving its global sales channels, as well as through pursuing strategic, complementary acquisitions. www.thesdigroup.net

Chairman's statement

With the world having only partially adapted to the coronavirus pandemic, it is pleasing to be able to report a broad-based return to levels of activity that are higher than those we saw before it started.  All, however, is not yet calm. The businesses are cogs in a machine that is trying to cope with changes in demand patterns caused by the pandemic, but also by longer term upheavals including a focus on healthcare, technological advancement, climate change and Brexit. 

I am more convinced than ever that SDI's business model, involving smaller niche businesses operating with a high degree of autonomy in technical, scientific and medical and life science market segments, offers a route to sustained value creation, and allows us to respond rapidly to events.

Trading

Our larger OEM customers have been ordering at good levels for some time now, with strong demand in healthcare, beverage can production and automotive racing in particular. Interest from customers for new products to be designed in and for capital equipment purchases for general laboratory use has remained subdued, although the restarting of trade fairs and exhibitions suggests that this too will bounce back now. Service activity is still hampered by travel restrictions but has lately been improving.

Supply chain issues have become a drain on management time, and our businesses are having to work hard to source components, modify designs for missing ones, and also to adapt to customer demand changes.  However, they are managing well.

The subsidiaries all worked hard to adapt to the changes in the half year, which was appreciated by the Board, and, I am sure, by shareholders.

Revenues 

Group revenues increased by 75% to £24.7m (FY21 H1: £14.1m).  The increase was driven by 3 major factors: 

-     Our Atik Cameras business continued to deliver, at a higher rate than in previous periods, cameras for use by a global OEM in RT PCR machines, which are (amongst other uses) the gold standard instrument for COVID-19 testing. We expect current orders, paid for in advance of shipment, to be fulfilled by January 2022, and we have no visibility of further orders.

-     The businesses we acquired in FY21 H2, Monmouth Scientific and Uniform Engineering, delivered £4.6m of sales, which was ahead of our expectations.

-     Our other businesses performed very well, recording collectively 22% sales growth compared with FY21 H1, which was of course affected by pandemic-related reductions in customer purchases.  All of these businesses have rebounded substantially, with the exception of the ventilator-related sales at MPB industries.

Organic revenue growth across the business was 42%. Compared with the same period of two years ago, FY20 H1, sales of those businesses in the Group at the time have increased by 59%. Excluding the exceptional 218% growth at Atik Cameras, all of those businesses have grown, at an average two-year growth of 16%.

Sales in our Digital Imaging segment grew by 64% to £11.4m (FY21 H1: £6.9m) and sales in Sensors & Control were 85% higher at £13.3m (FY21 H1: £7.2m).

Profits

Gross margin was lower than in FY21 H1, due essentially to the evolution of product mix, including the effect of below-average margins at Monmouth Scientific (acquired in FY21 H2) and on the Atik Camera orders. We have had to increase prices to offset the impacts of both labour cost increases and component and raw material price increases across the Group, and generally we have seen customer acceptance of this.

Overheads are higher than the comparative period which benefited from furlough receipts and from a virtual stop to travel costs, but we are seeing the benefit of efficiency gains realised over the past year.

Group profit before tax increased by 115% to £5.1m (FY21 H1: 2.4m), driven by the organic revenue growth and the contribution of the FY21 H2 acquired businesses. 

Our tax charge has increased by 288% to £1.5m (FY21 H1: £0.4m), essentially due to a £0.6m charge to align certain deferred tax assets and liabilities (except for deferred tax assets related to share options) to the new UK corporate tax rate of 25% from April 2023.  A £0.3m favourable impact from aligning the deferred tax asset for future share option gains to current share prices and tax rates has been booked directly to equity.

In addition to the GAAP results, the Group also provides adjusted results in which certain one-time and non-cash charges are excluded, to help shareholders understand the underlying operating performance.  Adjusted profit before tax increased by 90% to £5.7m (FY21 H1: £3.0m).  Adjustments for the period were for the amortisation of acquired intangible assets and for share based payments totalling £0.6m (FY21 H1: £0.5m).  No acquisition-related costs or reorganisation costs were recorded in the period (FY21 H1: £0.1m of reorganisation expense).

Basic earnings per share increased by 78% from 2.03p to 3.61p; diluted earnings per share increased by 76% to 3.43p (FY21 H1: 1.95p). Adjusted diluted EPS increased by 59% to 3.92p (FY21 H1: 2.47p).

Cash flow

Cash generated from operations reduced by 6% to £4.4m (FY21 H1: £4.7m).  The very strong cash flow of the previous year was strongly influenced by the build-up of advanced payments for the COVID-19-related orders at Atik Cameras (as reported at the time).  In the current period, these have reduced by about £1.1m, with consequent reduction to cash flow.  The remaining £1.8m is expected to unwind in the remaining months of the year as the orders are shipped.

During this period, we paid the deferred consideration element of £2.35m on the acquisition of Monmouth Scientific.

Net cash, or cash less bank debt, increased to £1.1m at 31 October 2021 from £0.8m at 30 April 2021.

On 01 November 2021, directly following the period end, we renewed and expanded our committed loan facility with HSBC to £20m, with a further accordion option of an additional £10m (at the discretion of HSBC), which, with our current net cash position and strong cash flow, provides sufficient funding for acquisition opportunities. The new facility has been tailored to our business model with fewer restrictions on acquisitions and allows for higher leverage if necessary. 

Operations

This half year has been a challenging one for our operations teams, with relatively short-term changes in customer demand, usually upwards but also impacted by customers' ability to source other key components, and with upstream shortages of our own components and materials. Significant management time has been expended in negotiating additional supplies and finding alternative sources or designing in substitute components. We expect this situation to endure for some time, and we have also increased purchases in many cases to secure key inputs.

Labour availability has been less of a problem, with generally low turnover as usual, but some vacancies taking time to fill.

We are seeing cost increases in both material and labour, but we are generally able to pass these on to customers.

As part of a rolling programme of upgrading facilities, we have been investing in an upgrade and capacity expansion at Graticules Optics to create a modern factory that is able to expand into new areas  and have made further investments at Uniform Engineering for efficiency, capacity and quality.  We have been strengthening the Portugal-based team at Atik Cameras so that they can directly handle all day-to-day interaction with the global customer-base, leaving Norwich as the centre of excellence for product development, marketing and new business.

Our business units have only recently started to attend and exhibit at trade fairs and exhibitions after a difficult period of demonstrating and marketing products via videoconference. Design-in activity with OEM customers is also picking up again, whereas research and development has continued throughout the pandemic period within our business units.

Acquisitions

No major acquisition took place in the period, but in August 2021, we purchased the Clean Tent trade and assets from Moorfield Technology, for a cash consideration of £150,000, which was integrated into Monmouth Scientific. Clean Tents are portable and temporary cleanroom facilities, which are complementary to the Monmouth Scientific range and we are very pleased with this purchase.

The Group continues to look for complementary acquisitions fitting our criteria, and we would hope to close at least one in the financial year.

Outlook

As we have previously disclosed, we expect sales and therefore profit in the second half of the year to be lower than in the first half, as the COVID-19-related orders at Atik have been mostly completed.  Apart from this, we expect a continuation of favourable trading conditions seen in the first half and look forward to delivering a full year performance in line with market expectations.

Ken Ford, Chairman

6 December 2021

Consolidated income statement

Unaudited for the six months ended 31 October 2021

Note 6 months to

31 October

2021

Unaudited

£'000
6 months to

31 October

2020

Unaudited

£'000
12 months to

30 April

2021

Audited

£'000
Revenue 24,655 14,126 35,076
Costs of sales (8,783) (4,724) (12,206)
Gross Profit 15,882 9,402 22,870
Other operating income 20 7 21
Operating expenses (10,695) (6,874) (16,960)
Operating profit 5,207 2,535 5,931
Net financing expense (105) (164) (287)
Profit before taxation 5,102 2,371 5,644
Income tax charge 8 (1,526) (393) (936)
Profit for the period 3,576 1,978 4,708
Earnings per share 5
Basic earnings per share 3.61p 2.03p 4,81p
Diluted earnings per share 3.43p 1.95p 4.58p

Consolidated statement of comprehensive income

Unaudited for the six months ended 31 October 2021

6 months to

31 October

2021

Unaudited

£'000
6 months to

31 October

2020

Unaudited

£'000
12 months to

30 April

2021

Audited

£'000
Profit for the period 3,576 1,978 4,708
Other comprehensive income
Exchange differences on translating foreign operations (161) 48 (96)
Total comprehensive profit for the period 3,415 2,026 4,612

Consolidated balance sheet

Unaudited at 31 October 2021

Note 31 October

2021

Unaudited

£'000
31 October

2020

Unaudited

£'000
30 April

2021

Audited

£'000
Assets
Non-current assets
Intangible assets 25,730 21,110 26,237
Property, plant and equipment 4,225 3,584 4,131
Deferred tax asset 8 1,660 219 1,697
31,615 24,913 32,065
Current assets
Inventories 6,957 4,087 6,059
Trade and other receivables 7,786 4,456 6,743
Cash and cash equivalents 3,513 3,436 3,836
18,256 11,979 16,638
Total assets 49,871 36,892 48,703
Liabilities
Non-current liabilities
Borrowings 6 1,029 2,400 1,714
Lease liabilities 6 1,936 2,211 2,050
Deferred tax liability 8 2,993 2,037 2,479
5,958 6,648 6,243
Current liabilities
Trade and other payables 9,727 5,412 12,826
Provisions 230 85 230
Borrowings 6 1,371 1,371 1,371
Lease liabilities 6 498 562 509
Current tax payable 1,165 510 750
12,991 7,940 15,686
Total liabilities 18,949 14,588 21,929
Net assets 30,922 22,304 26,774
Equity
Share capital 996 978 984
Merger reserve 2,606 2,606 2,606
Merger relief reserve 424 424 424
Share premium account 9,359 8,805 9,092
Share-based payment reserve 728 619 714
Foreign exchange reserve (76) 229 85
Retained earnings 16,885 8,643 12,869
Total equity 30,922 22,304 26,774

Consolidated statement of cash flows

Unaudited for the six months ended 31 October 2021

Note 6 months to

31 October

2021

Unaudited

£'000
6 months to

31 October

2020

Unaudited

£'000
12 months to

30 April

2021

Audited

£'000
Operating activities
Net profit for the period 3,577 1,978 4,708
Depreciation and amortisation 1,315 1,096 2,562
Finance costs and income 105 164 287
Impairment of intangibles - 18 130
Changes in provisions - - (15)
Taxation expense in the income statement 1,526 393 936
Employee share-based payments 159 152 305
Operating cash flow before movement in working capital 6,682 3,801 8,913
Changes in inventories (886) (400) (977)
Changes in trade and other receivables (573) (745) (2,363)
Changes in trade and other payables (808) 2,059 6,137
Cash generated from operations 4,415 4,715 11,710
Interest paid (105) (164) (287)
Income taxes paid (735) (493) (1,166)
Cash generated from operating activities 3,575 4,058 10,257
Cash flows from investing activities
Capital expenditure on fixed assets (510) (109) (667)
Sale of property plant and equipment 32 - 67
Expenditure on development and other intangibles (115) (116) (367)
Acquisition of subsidiaries, net of cash 7 (2,500) - (4,057)
Net cash used in investing activities (3,093) (225) (5,024)
Cash flows from financing activities
Payments of lease liabilities (296) (224) (489)
Proceeds from bank borrowings - - 5,404
Repayment of borrowings (686) (5,562) (11,652)
Issues of shares & proceeds from option exercises 278 - 155
Net cash (used in)/from financing activities (704) (5,786) (6,582)
Net (decrease)/increase in cash and cash equivalents (222) (1,953) (1,349)
Cash and cash equivalents, beginning of period 3,836 5,290 5,290
Foreign currency movements on cash balances (101) 99 (105)
Cash and cash equivalents, end of period 3,513 3,436 3,836

Consolidated statement of changes in equity

Unaudited for the six months ended 31 October 2021

6 months to 31 October 2021 - unaudited Share

capital

£'000
Merger

reserve

£'000
Merger relief reserve

£'000
Foreign

exchange

£'000
Share

premium

£'000
Share-based payment reserve

£'000
Retained

earnings

£'000
Total

£'000
Balance at 1 May 2021 984 2,606 424 85 9,092 714 12,869 26,774
Shares issued 12 - - - 267 - - 279
Tax in respect to share options - - - - - - 295 295
Share-based payments transfer - - - - - (145) 145 -
Share based payments - - - - - 159 - 159
Transactions with owners 12 - - - 267 14 440 733
Profit for the period - - - - - - 3,576 3,576
Foreign exchange on consolidation of subsidiaries - - - (161) - - - (161)
Total comprehensive income for the period - - - (161) - - 3,576 3,415
Balance at 31 October 2021 996 2,606 424 (76) 9,359 726 16,885 30,922
6 months to 31 October 2020 - unaudited Share

capital

£'000
Merger

reserve

£'000
Merger relief reserve

£'000
Foreign

exchange

£'000
Share

premium

£'000
Share-based payment reserve

£'000
Retained

earnings

£'000
Total

£'000
Balance at 1 May 2020 975 3,030 - 181 8,746 467 6,665 20,064
Shares issued 3 - - - 59 - - 62
Share based payments - - - - - 152 - 152
Transactions with owners 3 - - - 59 152 - 214
Profit for the period - - - - - - 1,978 1,978
Foreign exchange on consolidation of subsidiaries - - - 48 - - - 48
Total comprehensive income for the period - - - 48 - - 1,978 2,026
Balance at 31 October 2020 978 3,030 - 229 8,805 619 8,643 22,304
12 months to 30 April 2021 - audited Share

capital

£'000
Merger

reserve

£'000
Merger relief reserve

£'000
Foreign

exchange

£'000
Share

premium

£'000
Share-based payment reserve

£'000
Retained

earnings

£'000
Total

£'000
Balance at 30 April 2020 975 3,030 - 181 8,746 467 6,665 20,064
Restatement - (424) 424 - - - - -
Adjusted balances at 30 April 2020 975 2,606 424 181 8,746 467 6,665 20,064
Shares issued 9 - - - 346 - - 355
Tax in respect to share options - - - - - - 1,438 1,438
Share-based payments transfer - - - - - (58) 58 -
Share based payments - - - - - 305 - 305
Transactions with owners 9 - - - 346 247 1,496 2,098
Profit for the year - - - - - - 4,708 4,708
Foreign exchange on consolidation of subsidiaries - - - (96) - - - (96)
Total comprehensive income - - - (96) - - 4,708 4,612
Balance at 30 April 2021 984 2,606 424 85 9,092 714 12,869 26,774

Notes to the interim financial statements

1. General information and basis of preparation

SDI Group plc (formerly known as Scientific Digital Imaging plc (the "Company")), a public limited company, is the Group's ultimate parent. It is registered in England and Wales. The consolidated interim financial statements of the Company for the period ended 31 October 2021 comprise the Company and its subsidiaries (together referred to as the "Group").

The unaudited consolidated interim financial statements are for the six months ended 31 October 2021. These interim financial statements have been prepared using the recognition and measurement principles of International Accounting Standards in conformity with the requirements of the Companies Act 2006. The consolidated interim financial information has been prepared under the historical cost convention, as modified by the recognition of certain financial instruments at fair value. The consolidated interim financial statements are presented in British pounds (£), which is also the functional currency of the ultimate parent company.

The consolidated interim financial information was approved by the Board of Directors on 6 December 2021

The financial information set out in this interim report does not constitute statutory accounts as defined in section 435 of the Companies Act 2006. The figures for the year ended 30 April 2021 have been extracted from the statutory financial statements of SDI Group plc which have been filed with the Registrar of Companies. The auditor's report on those financial statements was unqualified and did not contain a statement under section 498(2) or 498(3) of the Companies Act 2006. The financial information for the six months ended 31 October 2021 and for the six months ended 31 October 2020 has not been audited.

2. Principal accounting policies

The principal accounting policies adopted in the preparation of the condensed consolidated interim information are consistent with those followed in the preparation of the Group's financial statements for the year ended 30 April 2021.

The accounting policies have been applied consistently throughout the Group for the purposes of preparation of these interim financial statements.

3. Alternative Performance Measures

The Group uses Adjusted Operating Profit, Adjusted Profit Before Tax, Adjusted Diluted EPS and Net Operating Assets as supplemental measures of the Group's profitability and investment in business related assets, in addition to measures defined under IFRS. The Group considers these useful due to the exclusion of specific items that are considered to hinder comparison of underlying profitability and investments of the Group's segments and businesses and is aware that shareholders use these measures to evaluate performance over time. The adjusting items for the alternative measures of profit are either recurring but non-cash charges (share-based payments and amortisation of acquired intangible assets) or exceptional items (reorganisation costs and acquisition costs).

The following table is included to define the term Adjusted Operating Profit:

6 months to

31 October

2021

Unaudited

£'000
6 months to

31 October

2020

Unaudited

£'000
12 months to

30 April

2021

Audited

£'000
Operating Profit (as reported) 5,207 2,535 5,931
Adjusting items (all costs):
Non-underlying items
Share based payments 159 152 305
Amortisation of acquired intangible assets 465 379 1,153
Exceptional items
Reorganisation costs - 129 132
Acquisition and fundraising costs - - 179
Total adjusting items within Operating Profit 624 660 1,769
Adjusted Operating Profit 5,831 3,195 7,700

Adjusted Profit Before Tax is defined as follows:

6 months to

31 October

2021

Unaudited

£'000
6 months to

31 October

2020

Unaudited

£'000
12 months to

30 April

2021

Audited

£'000
Profit Before Tax (as reported) 5,102 2,371 5,644
Adjusting items (as above) 624 660 1,769
Adjusted Profit Before Tax 5,726 3,031 7,413

3. Alternative Performance Measures (continued)

Adjusted EPS is defined as follows:

6 months to

31 October

2021

Unaudited

£'000
6 months to

31 October

2020

Unaudited

£'000
12 months to

30 April

2021

Audited

£'000
Profit for the Period (as reported) 3,576 1,978 4,708
Adjusting items (as above) 624 660 1,769
Less: taxation on adjusting items calculated at the UK statutory rate (119) (125) (336)
Adjusted profit for the period 4,081 2,513 6,141
Divided by diluted weighted average number of shares in issue (Note 5) 104,138,768 101,611,426 102,799,084
Adjusted Diluted EPS 3.92p 2.47p 5.97p

Net Operating Assets is defined as follows:

31 October

2021

Unaudited

£'000
31 October

2020

Unaudited

£'000
30 April

2021

Audited

£'000
Net Assets 30,922 22,304 26,774
Deferred tax asset 1,660 219 1,697
Corporation tax asset 486 79 17
Cash and cash equivalents 3,513 3,436 3,836
Borrowings (current and non-current) (4,834) (6,544) (5,644)
Deferred consideration - - (2,350)
Deferred tax liability (2,993) (2,037) (2,479)
Current tax payable (1,165) (510) (750)
Total adjusting items within Net Assets (3,333) (5,357) (5,673)
Net Operating Assets 34,255 27,661 32,447

4. Segmental analysis

6 months to

31 October

2021

Unaudited

£'000
6 months to

31 October

2020

Unaudited

£'000
12 months to

30 April

2021

Audited

£'000
Revenues
Digital Imaging 11,373 6,940 15,778
Sensors & Control 13,292 7,186 19,288
Group 24,665 14,126 35,076
Adjusted Operating Profit
Digital Imaging 4,253 2,075 5,165
Sensors & Control 2,505 1,569 4,360
Other (927) (449) (1,825)
Group 5,831 3,195 7,700
Amortisation of acquired intangible assets
Digital Imaging (92) (92) (175)
Sensors & Control (377) (291) (978)
Group (469) (383) (1,153)

Adjusted Operating Profit has been defined in Note 3.

Analysis of amortisation of acquired intangible assets has been included separately as the Group considers it to be an important component of profit which is directly attributable to the reported segments.

The Other category includes costs which cannot be allocated to the other segments and consists principally of Group head office costs. 

4. Segmental analysis (continued)

31 October

2021

Unaudited

£'000
31 October

2020

Unaudited

£'000
30 April

2021

Audited

£'000
Operating Assets excluding acquired intangible assets
Digital Imaging 9,612 6,942 7,895
Sensors & Control 9,757 5,825 9,683
Other (257) 331 131
Group 19,112 13,098 17,709
Acquired intangible assets
Digital Imaging 5,107 5,282 5,195
Sensors & Control 19,978 14,777 20,251
Group 25,085 20,059 25,446
Operating Liabilities
Digital Imaging (4,650) (3,051) (5,439)
Sensors & Control (4,192) (2,200) (4,204)
Other (1,101) (245) (1,064)
Group (9,943) (5,496) (10,707)
Net Operating Assets
Digital Imaging 10,069 9,173 7,650
Sensors & Control 25,543 18,402 25,731
Other (1,357) 86 (934)
Group 34,255 27,661 32,447

Net operating assets has been defined in Note 3.

5. Earnings per share

The calculation of the basic earnings per share is based on the profits attributable to the shareholders of SDI Group plc divided by the weighted average number of shares in issue during the period. All profit per share calculations relate to continuing operations of the Group.

Profit

 attributable to

shareholders

£'000
Weighted

average

number of

shares
Earnings

per share

amount in

pence
Basic earnings per share:
Period ended 31 October 2021 3,576 99,120,392 3.61
Period ended 31 October 2020 1,978 97,582,755 2.03
Year ended 30 April 2021 4,708 97,852,313 4.81
Dilutive effect of share options:
Period ended 31 October 2021 5,018,376
Period ended 31 October 2020 4,028,671
Year ended 30 April 2021 4,946,771
Diluted earnings per share:
Period ended 31 October 2021 3,576 104,138,768 3.43
Period ended 31 October 2020 1,978 101,611,426 1.95
Year ended 30 April 2021 4,708 102,799,084 4.58

6. Borrowings

31 October

2021

£'000
31 October

2020

£'000
30 April

2021

£'000
Within one year:
Bank finance 1,371 1,371 1,371
Leases 498 562 509
1,869 1,933 1,880
After one year and within five years:
Bank finance 1,029 2,400 1,714
Leases 1,065 1,297 2,050
2,094 3,697 3,764
After more than five years:
Leases 871 914 -
Total borrowings 4,834 6,544 5,644

Bank finance relates to amounts drawn down under the Group's bank facility with HSBC Bank plc, which is secured against all assets of the Group.

On 01 November, directly after the period end, the Group agreed a new £20m revolving loan facility with HSBC, committed for 3 years, with covenants relating to leverage (net debt to EBITDA) and interest coverage. The £2,400,000 of short term and long-term bank finance shown above was transferred to the new facility.

7. Acquisitions

During the previous financial year, the Group completed the acquisition of Monmouth Scientific Limited for which contingent consideration of £2.35 million was outstanding at 30 April 2021.  This amount was settled in cash in the current period.

On 12 August 2021, Monmouth Scientific acquired the trade and assets of the Clean Tent business, for a cash consideration of £150,000.

8. Taxation

The Group has estimated an effective tax rate of 18.1% for the year and has applied this rate to the profit before tax for the period. The Group has further booked a charge of £597,000 to align certain deferred tax assets and liabilities to the new statutory tax rate of 25% enacted for periods from March 2023. A gain of £295,000 resulting from changes to the estimate of future tax relief from share option exercises, including the estimated effect of changes in the tax rate, has been booked directly to equity.

SDl Group plc

Beacon House

Nuffield Road

Cambridge

CB4 1TF

UK

Telephone:          +44 (0)1223 727144

Fax:                       +44 (0)1223 727101

Email:                    [email protected]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

IR UPGUPPUPGPGQ